Eosinophilic peritonitis induced by sucroferric oxyhydroxide.


Journal

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
ISSN: 1718-4304
Titre abrégé: Perit Dial Int
Pays: United States
ID NLM: 8904033

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 29 3 2020
medline: 3 8 2021
entrez: 29 3 2020
Statut: ppublish

Résumé

A 49-year-old woman developed eosinophilic peritonitis 2 months after starting continuous ambulatory peritoneal dialysis because of congenital right kidney hypoplasia and chronic glomerulonephritis. This was shown to have been induced by sucroferric oxyhydroxide, an iron-based phosphate binder, using a drug-induced lymphocyte stimulation test. Her eosinophilic peritonitis was improved after stopping the administration of sucroferric oxyhydroxide without providing any immunosuppressive agents.

Identifiants

pubmed: 32216579
doi: 10.1177/0896860820915019
doi:

Substances chimiques

Drug Combinations 0
Ferric Compounds 0
sucroferric oxyhydroxide 0
Sucrose 57-50-1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

419-421

Auteurs

Saori Minato (S)

Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Japan.

Haruhisa Miyazawa (H)

Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Japan.

Taisuke Kitano (T)

Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Japan.

Mitsutoshi Shindo (M)

Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Japan.

Kiyonori Ito (K)

Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Japan.

Yuichiro Ueda (Y)

Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Japan.

Keiji Hirai (K)

Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Japan.

Taro Hoshino (T)

Division of Nephrology, Saitama Red Cross Hospital, Japan.

Susumu Ookawara (S)

Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Japan.

Yoshiyuki Morishita (Y)

Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH